Immunization Planner

Read each patient’s profile, decide which vaccines are due today, catch what is contraindicated or needs a precaution, and work out when the next dose can be given. For due-today questions, select every vaccine that applies.

Decisions correct: 0 / 0
References

American Academy of Family Physicians. (2026a). Adults 19 and older immunization schedules. https://www.aafp.org/clinical-insights/immunizations-and-vaccines/immunizations-schedules-resources/adult-immunization-schedules

American Academy of Family Physicians. (2026b). Birth through age 18 immunization schedules. https://www.aafp.org/clinical-insights/immunizations-and-vaccines/immunizations-schedules-resources/childhood-vaccine-schedules

American Academy of Family Physicians. (2026c). 2026–2027 influenza, RSV and SARS-CoV-2 immunization recommendations: For non-pregnant immunocompetent adults and health care personnel. https://www.aafp.org/assets/image/upload/v1788277985/pdf_2026_through_2027_influenza_rsv_sars_covid_2_guidance.pdf

American College of Obstetricians and Gynecologists. (2026a, June 10). 2026 maternal immunization schedule. https://www.acog.org/clinical-information/maternal-immunization-schedule

American College of Obstetricians and Gynecologists. (2026b, September 2). ACOG releases 2026–27 respiratory virus season immunization recommendations for pregnant and postpartum individuals [Press release]. https://www.acog.org/news/news-releases/2026/09/acog-releases-2026-27-respiratory-virus-season-immunization-recommendations

Belden, K., Nellore, A., Goepfert, P., Tan, C. S., Bajema, K., Blumberg, D., Katz, M. J., Kaul, D., Sharma, T., Anjan, S., Ariza-Heredia, E. J., Magana, F., Minniear, T., Loveless, J., Kaur, D., Patel, S., York, E., Falck-Ytter, Y., & Baden, L. (2026, September 2). IDSA 2026 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients. Infectious Diseases Society of America. https://www.idsociety.org/practice-guideline/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/

Centers for Disease Control and Prevention. (2024, July 9). Clinical considerations for Shingrix use in immunocompromised adults aged ≥19 years. https://www.cdc.gov/shingles/hcp/vaccine-considerations/immunocompromised-adults.html

Centers for Disease Control and Prevention. (2026, September 1). Interim clinical considerations for the use of seasonal influenza vaccines in the United States. https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html

Committee on Infectious Diseases. (2026a). Recommendations for COVID-19 vaccines in infants, children, and adolescents, 2026–2027: Policy statement. Pediatrics. Advance online publication. https://doi.org/10.1542/peds.2026-079045

Committee on Infectious Diseases. (2026b). Recommendations for prevention and control of influenza in children, 2026–2027: Policy statement. Pediatrics. Advance online publication. https://doi.org/10.1542/peds.2026-078778

Miller, E., & Wodi, A. P. (2024, April 22). Chapter 2: General best practice guidance for immunization. Centers for Disease Control and Prevention. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-2-general-best-practice-guidance.html

For education and exam preparation only. Answers use the 2026 AAFP adult and child schedules, 2026–2027 respiratory-virus guidance from AAFP, AAP, and IDSA, ACOG maternal guidance, and CDC best-practice and product-specific guidance. Recommendations can change during a respiratory-virus season; verify current guidance, product labeling, and local policy before vaccinating.

Last reviewed: September 24, 2026.